[EN] FUSED ISOXAZOLYL COMPOUNDS AS KAT6A INHIBITORS [FR] COMPOSÉS ISOXAZOLYLES FUSIONNÉS UTILISÉS EN TANT QU'INHIBITEURS DE KAT6A
摘要:
The present invention provides fused isoxazolyl compound of formula (I), which are therapeutically useful as KAT6A inhibitors particularly in the treatment and/or prevention of diseases or disorders dependent upon KAT6A in a mammal. The present invention also provides preparation of the compounds and pharmaceutical compositions comprising at least one of the compound represented by formula (I) or a pharmaceutically acceptable salt or a stereoisomer or a tautomer thereof.